Biochemical Society Transactions (1 995) 23 1 93s P21-ras is involved in regulation of voltage-dependent calcium channels in cultured rat dorsal root ganglion cells.
P21-ras in combination with ras-GAP has been found to block activation of atrial K+ channels by M2 muscarinic receptors (mAChRs), an effect which was suggested to involve interference with receptor-G-protein coupling [l] . Since both M2 and M4 mAChRs are known to inhibit Ca2' channels directly via the pertussis toxin (PTX)-sensitive G-protein, Go, p21-ras may also be involved in regulation of neuronal Ca2+ channels [2, 31. Here we report the results from a study in which the whole cell patch clamp technique has been used to examine the involvement of endogenous p21-ras in regulation of Ca" channels in primary cultured rat dorsal root ganglion cells (DRGs).
In preliminary ex eriments, the presence of the muscarinic agonist, carbachol(10' M) in the external medium caused a 32.0 * 4.0 YO (mean i s.e.m.) inhibition of calcium channel current, IBa.
Use of the M 1 M4-selective muscarinic antagonist, pirenzepine ( M), the M4-selective antagonist, himbacine ( M), and PTX (230 ng/ml for 15 h) suggested the involvement of a PTXsensitive M4 receptor in rat DRGs.
In DRGs microinjected with the p21-ras neutralising antibody (Y13-259, 0.1 mg/ml, 50 pl/cell) 2 h prior to experiments, a 43.7 f 4.0 % inhibition of IBa was observed in the presence of carbachol. This result was not significantly different from control cells injected with 1 mg/ml of mouse IgG (36.2 5 4.0 %) or from noninjected cells (42.9 * 4.0 %). The voltage-dependence of both activation and inactivation of IB, shifted between 5-10 mV in a depolarising direction in all three treatments following application of carbachol, although these shifts were not significant either within, or, between treatments. Thus, microinjection of Y 13-259 had no effect on the ability of the muscarinic agonist to inhibit I B~ Importantly, however, there was a significant reduction in both peak amplitude of maximum IBa (36.0 * 3.0 %, p < 0.05) and the maximum tail current amplitude (31.0 f 3.0 %, p < 0.05) in antibody-injected cells versus controls. No significant differences in the voltage-dependence of either activation or inactivation of maximum peak amplitude of IB, were observed between treatments. Thus, acute blockade of a pathway involving endogenous p21 -ras reduces calcium currents.
Intracellular application of phosphopeptides (10-1 5 amino acids) with the sequences of tyrosine autophosphorylation sites on protein tyrosine kinases involved in growth factor activation of p21-ras (NGFR, TRK490; EGFR1068; and CRK adaptor protein, CRK221; at 0.1 mg/ml) also reduced both the peak amplitude of IBa, and maximum tail current amplitude. Effects of these phosphopeptides are thought to be due to the blockade of productive SH2-SH3 interactions which are initiated during the activation of p21-ras by growth factors. Inclusion of TRK490 in the patch pipette for up to 10 min caused a significant reduction of both peak IB, (1 5.8 f 2 %, p < 0.05) and tail current (34.0 f 6.4 %, p < 0.05). Application of EGFR1068 for 10 min resulted in a 19.8 f 4.0 % reduction of IB, (significant at p < 0.05) , and reduced the tail current by 12.8 f 3.0 %, which was not significant. CRK221 caused a significant reduction of peak I B~ by 18.3 f 2.0 % (p < 0.05), and maximum tail current by 29.2 f 2.0 % (p < 0.01), with time. In control cells, neither the peak amplitude of Is,, nor the tail current amplitude changed significantly with time (up to 10 min). Similarly, internal application of a control ("scrambled") phosphopeptide, also had no ! .
significant effects on either the maximum peak amplitude of IB,, or the maximum tail current amplitude. No significant changes in voltage-dependence of either current activation or inactivation were observed either within, or, between any of the above treatments. Thus, blocking a pathway possibly involving growth factor activation of p21-ras also reduced calcium current amplitude in these cells.
In contrast, microinjection of oncogenic p21-K-ras (2 mg/ml, 24 h prior to experiments) caused a significant increase in the peak amplitude of maximum IBa (61 f 3.0 %, p < 0.01) when compared with control cells. Similarly, the maximum tail current amplitude also increased significantly by 59.7 * 3.0 % (p < 0.01) The voltagedependence of both activation and inactivation of the currents exhibited no significant differences in p21-K-ras-injected, versus control cells.
Thus, we have provided evidence that endogenous p2 1 -ras, possibly activated via a protein tyrosine kinase pathway, is involved in the regulation of Ca2+ channels in rat DRGs, although unlike in cardiac myocytes, it is not involved in muscarinic inhibition of these Ca" currents. These results tie in with other studies in which the injection of oncogenic p21-ras has been found to increase Ca2+ current in neuronal cells [4, 5, 6] .
